![Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review | Article Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review | Article](https://assets.cureus.com/uploads/figure/file/246471/lightbox_c1747cb0f40611ebb741a9a1e985fb6f-Add-a-little-bit-of-body-text-12.png)
Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review | Article
![Frontiers | Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma Frontiers | Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma](https://www.frontiersin.org/files/Articles/454940/fonc-09-00537-HTML/image_m/fonc-09-00537-g001.jpg)
Frontiers | Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
![Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies](https://www.mdpi.com/cancers/cancers-14-05473/article_deploy/html/images/cancers-14-05473-g001.png)
Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy | Scholarly Publications
![Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy](https://www.cell.com/cms/attachment/f15f10ba-24ab-43c4-94b1-06ab90bec4ed/gr1_lrg.jpg)
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy
![Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30453-x/MediaObjects/41467_2022_30453_Fig1_HTML.png)
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications
![Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/244642bf-33f8-469a-a9ca-0d7de2d9cdb6/gr1_lrg.gif)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology
![Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-019-0756-z/MediaObjects/13045_2019_756_Fig1_HTML.png)
Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text
![Biomedicines | Free Full-Text | Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype Biomedicines | Free Full-Text | Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype](https://pub.mdpi-res.com/biomedicines/biomedicines-11-00874/article_deploy/html/images/biomedicines-11-00874-ag.png?1679640819)